Cargando…

Towards a Four-Component GMMA-Based Vaccine against Shigella

Shigellosis remains a major public health problem around the world; it is one of the leading causes of diarrhoeal disease in low- and middle-income countries, particularly in young children. The increasing reports of Shigella cases associated with anti-microbial resistance are an additional element...

Descripción completa

Detalles Bibliográficos
Autores principales:	Micoli, Francesca, Nakakana, Usman N., Berlanda Scorza, Francesco
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8880054/ https://www.ncbi.nlm.nih.gov/pubmed/35214786 http://dx.doi.org/10.3390/vaccines10020328

Ejemplares similares

GMMA-Based Vaccines: The Known and The Unknown
por: Mancini, Francesca, et al.
Publicado: (2021)

Comparison of Shigella GMMA and glycoconjugate four-component formulations in animals
por: Di Benedetto, Roberta, et al.
Publicado: (2023)

Exploring the Role of GMMA Components in the Immunogenicity of a 4-Valent Vaccine against Shigella
por: Mancini, Francesca, et al.
Publicado: (2023)

Development of a Monocyte Activation Test as an Alternative to the Rabbit Pyrogen Test for Mono- and Multi-Component Shigella GMMA-Based Vaccines
por: Carson, Danielle, et al.
Publicado: (2021)

A next-generation GMMA-based vaccine candidate to fight shigellosis
por: Rossi, Omar, et al.
Publicado: (2023)

GMMA and Glycoconjugate Approaches Compared in Mice for the Development of a Vaccine against Shigella flexneri Serotype 6
por: Raso, Maria Michelina, et al.
Publicado: (2020)

Antibodies Elicited by the Shigella sonnei GMMA Vaccine in Adults Trigger Complement-Mediated Serum Bactericidal Activity: Results From a Phase 1 Dose Escalation Trial Followed by a Booster Extension
por: Micoli, Francesca, et al.
Publicado: (2021)

Complement-mediated serum bactericidal activity of antibodies elicited by the Shigella sonnei GMMA vaccine in adults from a shigellosis-endemic country: Exploratory analysis of a Phase 2a randomized study
por: Kapulu, Melissa C., et al.
Publicado: (2022)

Dissecting in Vitro the Activation of Human Immune Response Induced by Shigella sonnei GMMA
por: Tondi, Serena, et al.
Publicado: (2022)

Rapid generation of Shigella flexneri GMMA displaying natural or new and cross-reactive O-Antigens
por: Gasperini, Gianmarco, et al.
Publicado: (2022)

Dissecting the contribution of O-Antigen and proteins to the immunogenicity of Shigella sonnei generalized modules for membrane antigens (GMMA)
por: Mancini, Francesca, et al.
Publicado: (2021)

Effect of O-Antigen Chain Length Regulation on the Immunogenicity of Shigella and Salmonella Generalized Modules for Membrane Antigens (GMMA)
por: Gasperini, Gianmarco, et al.
Publicado: (2021)

GMMA Technology for the Development of Safe Vaccines: Meta-Analysis of Individual Patient Data to Assess the Safety Profile of Shigella sonnei 1790GAHB Vaccine in Healthy Adults, with Special Focus on Neutropenia
por: De Ryck, Iris, et al.
Publicado: (2022)

Correction to: GMMA Technology for the Development of Safe Vaccines: Meta-Analysis of Individual Patient Data to Assess the Safety Profile of Shigella sonnei 1790GAHB Vaccine in Healthy Adults, with Special Focus on Neutropenia
por: De Ryck, Iris, et al.
Publicado: (2022)

GMMA as an Alternative Carrier for a Glycoconjugate Vaccine against Group A Streptococcus
por: Palmieri, Elena, et al.
Publicado: (2022)

Production of a Shigella sonnei Vaccine Based on Generalized Modules for Membrane Antigens (GMMA), 1790GAHB
por: Gerke, Christiane, et al.
Publicado: (2015)

Prophylaxis and Treatment against Klebsiella pneumoniae: Current Insights on This Emerging Anti-Microbial Resistant Global Threat
por: Arato, Vanessa, et al.
Publicado: (2021)

GMMA Is a Versatile Platform to Design Effective Multivalent Combination Vaccines
por: Micoli, Francesca, et al.
Publicado: (2020)

Toward a Shigella Vaccine: Opportunities and Challenges to Fight an Antimicrobial-Resistant Pathogen
por: Raso, Maria Michelina, et al.
Publicado: (2023)

Characterization of Competitive ELISA and Formulated Alhydrogel Competitive ELISA (FAcE) for Direct Quantification of Active Ingredients in GMMA-Based Vaccines
por: Rossi, Omar, et al.
Publicado: (2020)

Novel Simple Conjugation Chemistries for Decoration of GMMA with Heterologous Antigens
por: Di Benedetto, Roberta, et al.
Publicado: (2021)

Quantitative proteomic analysis of Shigella flexneri and Shigella sonnei Generalized Modules for Membrane Antigens (GMMA) reveals highly pure preparations
por: Maggiore, Luana, et al.
Publicado: (2016)

Efficacy, safety, and immunogenicity of the Shigella sonnei 1790GAHB GMMA candidate vaccine: Results from a phase 2b randomized, placebo-controlled challenge study in adults
por: Frenck, Robert W., et al.
Publicado: (2021)

Salmonella Vaccine Study in Oxford (SALVO) trial: protocol for an observer-participant blind randomised placebo-controlled trial of the iNTS-GMMA vaccine within a European cohort
por: Hanumunthadu, Brama, et al.
Publicado: (2023)

New Kids on the Block: RNA-Based Influenza Virus Vaccines
por: Scorza, Francesco Berlanda, et al.
Publicado: (2018)

Generalized Modules for Membrane Antigens (GMMA), an outer membrane vesicle‐based vaccine platform, for efficient viral antigen delivery
por: Hu, Kai, et al.
Publicado: (2022)

A GMMA-CPS-Based Vaccine for Non-Typhoidal Salmonella
por: Sokaribo, Akosiererem S., et al.
Publicado: (2021)

A strategic model for developing vaccines against neglected diseases: An example of industry collaboration for sustainable development
por: Berlanda Scorza, Francesco, et al.
Publicado: (2022)

Neisseria meningitidis Factor H Binding Protein Surface Exposure on Salmonella Typhimurium GMMA Is Critical to Induce an Effective Immune Response against Both Diseases
por: Necchi, Francesca, et al.
Publicado: (2021)

Booster Vaccination With GVGH Shigella sonnei 1790GAHB GMMA Vaccine Compared to Single Vaccination in Unvaccinated Healthy European Adults: Results From a Phase 1 Clinical Trial
por: Launay, Odile, et al.
Publicado: (2019)

Functional assays to evaluate antibody-mediated responses against Shigella: a review
por: Boero, Elena, et al.
Publicado: (2023)

Investigating the Role of Antigen Orientation on the Immune Response Elicited by Neisseria meningitidis Factor H Binding Protein on GMMA
por: Alfini, Renzo, et al.
Publicado: (2022)

Setup and Characterization of a High-Throughput Luminescence-Based Serum Bactericidal Assay (L-SBA) to Determine Functionality of Human Sera against Shigella flexneri
por: Mancini, Francesca, et al.
Publicado: (2022)

High Yield Production Process for Shigella Outer Membrane Particles
por: Berlanda Scorza, Francesco, et al.
Publicado: (2012)

Universal influenza vaccines: Shifting to better vaccines
por: Berlanda Scorza, Francesco, et al.
Publicado: (2016)

Modulation of Endotoxicity of Shigella Generalized Modules for Membrane Antigens (GMMA) by Genetic Lipid A Modifications: RELATIVE ACTIVATION OF TLR4 AND TLR2 PATHWAYS IN DIFFERENT MUTANTS
por: Rossi, Omar, et al.
Publicado: (2014)

Enhanced Systemic Humoral Immune Response Induced in Mice by Generalized Modules for Membrane Antigens (GMMA) Is Associated with Affinity Maturation and Isotype Switching
por: Piccioli, Diego, et al.
Publicado: (2023)

Rationalizing the design of a broad coverage Shigella vaccine based on evaluation of immunological cross-reactivity among S. flexneri serotypes
por: Citiulo, Francesco, et al.
Publicado: (2021)

Long-Term Anti-Bacterial Immunity against Systemic Infection by Salmonella enterica Serovar Typhimurium Elicited by a GMMA-Based Vaccine
por: Fiorino, Fabio, et al.
Publicado: (2021)

Intra-Laboratory Evaluation of Luminescence Based High-Throughput Serum Bactericidal Assay (L-SBA) to Determine Bactericidal Activity of Human Sera against Shigella
por: Rossi, Omar, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_aq2860j8dj72ld3d3cn3a39ldd